1. Direct and Indirect Cost of Percutaneous Transluminal Coronary Angioplasty
- Author
-
Thomas Aversano, Alida Merrill, Alan L. Sorkin, and Sheila T. Fitzgerald
- Subjects
Adult ,Male ,Percutaneous transluminal coronary angioplasty ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Work Capacity Evaluation ,Coronary Disease ,Return to work ,Indirect costs ,Lag time ,Cost of Illness ,Internal medicine ,Angioplasty ,Humans ,Medicine ,Pharmacology (medical) ,Postoperative Period ,Prospective Studies ,Angioplasty, Balloon, Coronary ,Prospective cohort study ,business.industry ,Middle Aged ,Treatment Outcome ,Costs and Cost Analysis ,Cardiology ,Female ,Sick Leave ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
A prospective study of 53 patients employed in the 6-month period before coronary angioplasty was performed to determine the direct and indirect costs of lag time in work resumption. The total direct costs calculated were $273,480; indirect costs for this sample were $150,944. When these costs are generalized to all patients in the US undergoing uncomplicated percutaneous transluminal coronary angioplasty, the costs are more than $1.2 billion. This study demonstrated that even in patients with a high a priori probability of work return, delay in work resumption results in a greater cost to the individual and society through absence from the labor force.
- Published
- 1994